| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jingjing Liu, Hongye Tang, Tingting Lin, Jiangchuan Wang, Wenjing Cui, Chao Xie, Zhongqiu Wang, Yugen Chen, Xiao Che. Sarcopenia assessed by CT or MRI is associated with the loss of response to biologic therapies in adult patients with Crohn's disease. Clinical and translational science. 2023-08-25. PMID:37621024. |
sarcopenia was also associated with lor in patients who received infliximab (or = 3.31, 95% ci: 1.11-9.87). |
2023-08-25 |
2023-09-07 |
Not clear |
| Yawen Quan, Chang Wang, Linfeng Wang, Gang L. Geriatric sarcopenia is associated with hypertension: A systematic review and meta-analysis. Journal of clinical hypertension (Greenwich, Conn.). 2023-08-18. PMID:37594142. |
the odds ratio (or) and 95% confidence interval (ci) was pooled to evaluate the correlation between sarcopenia and hypertension in older people utilizing a random-effects model. |
2023-08-18 |
2023-09-07 |
human |
| Yawen Quan, Chang Wang, Linfeng Wang, Gang L. Geriatric sarcopenia is associated with hypertension: A systematic review and meta-analysis. Journal of clinical hypertension (Greenwich, Conn.). 2023-08-18. PMID:37594142. |
the results revealed a substantial correlation between sarcopenia and hypertension among older people (or = 1.39, 95% ci: 1.15-1.67, p < .01). |
2023-08-18 |
2023-09-07 |
human |
| Chaomin Zhou, Lin Zhan, PignHong He, Jing Yuan, Yan Zh. Associations of sarcopenic obesity vs either sarcopenia or obesity alone with cognitive impairment risk in patients requiring maintenance hemodialysis. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2023-08-01. PMID:37525570. |
furthermore, we would explore and compare the associations between so, sarcopenia, and obesity with ci risk in this population. |
2023-08-01 |
2023-08-14 |
Not clear |
| Seunghyeok Song, Gushik Kim, Hyunjoong Ki. A Systematic Review and Meta-Analysis of Exercise Beneficial for Locomotion in Community-Dwelling Elderly People with Sarcopenia. Journal of functional morphology and kinesiology. vol 8. issue 3. 2023-07-25. PMID:37489305. |
exercise interventions were found to not change muscle mass in individuals with sarcopenia (smd = 0.04; 95% ci: -0.15 to 0.22). |
2023-07-25 |
2023-08-14 |
Not clear |
| Yuxuan Li, Juan Hou, Rongfeng Che. Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE. Medicine. vol 102. issue 27. 2023-07-07. PMID:37417609. |
according to the results of multifactor analysis, sarcopenic visceral obesity (hr = 8.35, 95% confidence intervals [ci] = [4.96, 14.05], p < .001) is more effective than any single or combined prognosis assessment, including sarcopenic dystrophy (hr = 2.70, 95% ci = [1.85, 3.95], p < .001), sarcopenic obesity (hr = 5.23, 95% ci = [3.41, 8.02], p < .001), sarcopenia (hr = 5.74, 95% ci = [3.61, 9.11], p < .001) and visceral obesity (hr = 3.44, 95% ci = [2.24, 5.27], p < .001). |
2023-07-07 |
2023-08-14 |
Not clear |
| Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Cho. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clinical and molecular hepatology. 2023-07-05. PMID:37403320. |
in regression analysis, both sarcopenia (men: odds ratio (or) 1.41, 95% confidence interval (ci) 1.19-1.67, p<0.001; women: or=1.59, 95% ci 1.40-1.90, p<0.001) and myosteatosis (men: or=1.24, 95% ci 1.02-1.50, p=0,028; women: or=1.23, 95% ci 1.04-1.46, p=0.017) were significantly associated with non-obese nafld after considering for vfo and other various risk factors, whereas vfo (men: or=3.97, 95% ci 3.43-¬4.59 [adjusted for sarcopenia], or 3.98, 95% ci 3.44-4.60 [adjusted for myosteatosis]; women: or=5.42, 95% ci 4.53-6.42 [adjusted for sarcopenia], or=5.33, 95% ci 4.51-6.31 [adjusted for myosteatosis]; all p<0.001) was strongly associated with non-obese nafld after adjustment with various known risk factors. |
2023-07-05 |
2023-08-14 |
Not clear |
| Reshma Aziz Merchant, Yiong Huak Chan, Denishkrshna Anbarasan, Ivan Aprahamia. Association of Motoric Cognitive Risk Syndrome with Sarcopenia and Systemic Inflammation in Pre-Frail Older Adults. Brain sciences. vol 13. issue 6. 2023-06-28. PMID:37371414. |
compared to healthy patients, mcr was significantly associated with sarcopenia (aor 2.62; 95% ci 1.46-3.17), bf% (aor 1.06; 95% ci 1.01-1.12), fmi (aor 1.16; 95% ci 1.02-1.30) and fm/ffm (aor 6.38; 95% ci 1.20-33.98). |
2023-06-28 |
2023-08-14 |
Not clear |
| Reshma Aziz Merchant, Yiong Huak Chan, Denishkrshna Anbarasan, Ivan Aprahamia. Association of Motoric Cognitive Risk Syndrome with Sarcopenia and Systemic Inflammation in Pre-Frail Older Adults. Brain sciences. vol 13. issue 6. 2023-06-28. PMID:37371414. |
the association of il-10 to tnf-α ratio (aor 0.98, 95% ci 0.97-0.99) and il-10 (aor 2.22, 95% ci 0.05-0.98) with mcr were independent of sarcopenia and bf%. |
2023-06-28 |
2023-08-14 |
Not clear |
| Joshua P Sutherland, Ang Zhou, Elina Hyppöne. Muscle Traits, Sarcopenia, and Sarcopenic Obesity: A Vitamin D Mendelian Randomization Study. Nutrients. vol 15. issue 12. 2023-06-28. PMID:37375607. |
for probable sarcopenia risk, there was suggestive evidence for lower odds by higher 25(oh)d (or 0.96 (95% ci 0.92, 1.00)); however, this did not reflect an association with sarcopenic obesity (or 0.97 (95% ci 0.93, 1.02)), but was seen in probable sarcopenia cases who were not obese (or 0.92 (95% ci 0.86, 0.98)). |
2023-06-28 |
2023-08-14 |
mouse |
| Motoki Furutani, Mutsumi Suganuma, Shintaro Akiyama, Risa Mitsumori, Marie Takemura, Yasumoto Matsui, Shosuke Satake, Yukiko Nakano, Shumpei Niida, Kouichi Ozaki, Tohru Hosoyama, Daichi Shigemiz. RNA-sequencing analysis identification of potential biomarkers for diagnosis of sarcopenia. The journals of gerontology. Series A, Biological sciences and medical sciences. 2023-06-22. PMID:37347997. |
we used clinical data which were not included diagnosis criteria of sarcopenia, and stride length showed significance by logistic regression analysis (bonferroni corrected p = .012, odds ratio = 0.06, 95% confidence interval [ci]: 0.05 to 0.40). |
2023-06-22 |
2023-08-14 |
Not clear |
| Sawan Ali, Graziamaria Corbi, Alessandro Medoro, Mariano Intrieri, Giovanni Scapagnini, Sergio Davinell. Relationship between monounsaturated fatty acids and sarcopenia: a systematic review and meta-analysis of observational studies. Aging clinical and experimental research. 2023-06-20. PMID:37340168. |
the results revealed that mufa intake is inversely associated with sarcopenia (standardized mean difference = - 0.28, 95% ci - 0.46 to - 0.11; p < 0.01). |
2023-06-20 |
2023-08-14 |
human |
| Dongwoo Kim, Yu Jin Lee, Eui Seop Song, Ahreum Kim, Cho Hee Bang, Jae Hyun Jun. The High Prevalence of Sarcopenia in Rheumatoid Arthritis in the Korean Population: A Nationwide Cross-Sectional Study. Healthcare (Basel, Switzerland). vol 11. issue 10. 2023-05-27. PMID:37239687. |
after adjusting for potential confounding variables, the prevalence of sarcopenia was higher in men with ra than in men without ra (or, 3.11; 95% ci, 1.29-7.46), but this difference was not observed in women. |
2023-05-27 |
2023-08-14 |
human |
| Dongwoo Kim, Yu Jin Lee, Eui Seop Song, Ahreum Kim, Cho Hee Bang, Jae Hyun Jun. The High Prevalence of Sarcopenia in Rheumatoid Arthritis in the Korean Population: A Nationwide Cross-Sectional Study. Healthcare (Basel, Switzerland). vol 11. issue 10. 2023-05-27. PMID:37239687. |
in subgroup analysis which was stratified by age (age under 40, age between 40 and 59, age over 60), the or for sarcopenia was higher in men with age over 60 years (or, 4.12; 95% ci, 1.48-11.44) and women with age between 40 and 59 (or, 2.29; 95% ci, 1.05-5.00). |
2023-05-27 |
2023-08-14 |
human |
| Takushi Manabe, Chikara Ogawa, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Mitsushige Shibatoge, Asahiro Morishita, Masatoshi Kudo, Tsutomu Masak. Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease. Diagnostics (Basel, Switzerland). vol 13. issue 7. 2023-04-13. PMID:37046463. |
all diagnostic methods showed that patients with sarcopenia had shorter survival, with o-pmi having the highest hazard ratio (hr) (hr, 6.12; 95% confidence interval [ci], 2.6-14.41; |
2023-04-13 |
2023-08-14 |
Not clear |
| Xinrong Zuo, Xuehong Li, Kuo Tang, Rui Zhao, Minming Wu, Yang Wang, Tao L. Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis. Journal of cachexia, sarcopenia and muscle. 2023-04-01. PMID:37002802. |
the prevalence of sarcopenia ranged from 10.1% to 68.9% in patients with cvds, and the pooled prevalence was 35% (95% confidence interval [95% ci]: 28-42%). |
2023-04-01 |
2023-08-14 |
human |
| Xinrong Zuo, Xuehong Li, Kuo Tang, Rui Zhao, Minming Wu, Yang Wang, Tao L. Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis. Journal of cachexia, sarcopenia and muscle. 2023-04-01. PMID:37002802. |
the pooled prevalence of sarcopenia was 32% (95% ci: 23-41%) in patients with chronic heart failure (chf), 61% (95% ci: 49-72%) in patients with acute decompensated heart failure (adhf), 43% (95% ci: 2-85%) in patients with coronary artery disease, 30% (95% ci: 25-35%) in patients with cardiac arrhythmia (ca), 35% (95% ci: 10-59%) in patients with congenital heart disease and 12% (95% ci: 7-17%) in patients with unclassed cvds. |
2023-04-01 |
2023-08-14 |
human |
| Xinrong Zuo, Xuehong Li, Kuo Tang, Rui Zhao, Minming Wu, Yang Wang, Tao L. Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis. Journal of cachexia, sarcopenia and muscle. 2023-04-01. PMID:37002802. |
however, in the general population, the prevalence of sarcopenia varied from 2.9% to 28.6% and the pooled prevalence was 13% (95% ci: 9-17%), suggesting that the prevalence of sarcopenia in patients with cvds was about twice compared with the general population. |
2023-04-01 |
2023-08-14 |
human |
| Molly Curtis, Lauren Swan, Rebecca Fox, Austin Warters, Maria O'Sulliva. Associations between Body Mass Index and Probable Sarcopenia in Community-Dwelling Older Adults. Nutrients. vol 15. issue 6. 2023-03-29. PMID:36986233. |
(3) results: our overall findings show that an underweight bmi was significantly associated with an increased likelihood of probable sarcopenia [or (ci) 2.25 (1.17, 4.33), |
2023-03-29 |
2023-08-14 |
Not clear |
| Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Natee Ina, Ply Chichareo. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study. Scientific reports. vol 13. issue 1. 2023-03-09. PMID:36894658. |
the rate of tace response in patients with sarcopenia was not different from those without sarcopenia (60.91% vs. 65.22%, adjusted or 0.79, 95% ci 0.55-1.13). |
2023-03-09 |
2023-08-14 |
Not clear |